Compass Therapeutics Inc.
CMPX
$1.17-5.65%
End of day · as of Sep 24, 2026, 7:30 AM ET
Mkt cap
$367.38M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
N/A
EPS (TTM)
$-0.39
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
0.74
Div yield
N/A
Sector
Healthcare
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
Latest reported CMPX revenue for 2025-12-31 was $0. Net income was -$66.5M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. CMPX currently screens at market cap $367.4M.
Use this CMPX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CMPX income, balance, and cash tables.
Compass Therapeutics Inc. (CMPX) is a biotechnology company in the Healthcare sector.
Latest cached Compass Therapeutics Inc. (CMPX) net income for Dec 31, 2025 was -$66.5M. Statements: https://lician.com/financials/cmpx
Compass Therapeutics Inc. (CMPX) market capitalization is $367.4M on the latest cached snapshot.
Compass Therapeutics Inc. (CMPX) cached previous close $1.24; day range $1.13 – $1.23; volume 7,670,668. Session quote: https://lician.com/quote/cmpx
Compass Therapeutics Inc. (CMPX) latest cached earnings event is "CMPX earnings" on Aug 10, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CMPX filing is 8-K · Sep 22, 2026. Filings: https://lician.com/sec/cmpx